Higano, C. S., Beer, T. M., Taplin, M., Efstathiou, E., Hirmand, M., Forer, D., & Scher, H. I. (2015). Long-term Safety and Antitumor Activity in the Phase 1–2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer. Eur Urol.
Citação norma ChicagoHigano, Celestia S., Tomasz M. Beer, Mary-Ellen Taplin, Eleni Efstathiou, Mohammad Hirmand, David Forer, and Howard I. Scher. "Long-term Safety and Antitumor Activity in the Phase 1–2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer." Eur Urol 2015.
MLA CitationHigano, Celestia S., et al. "Long-term Safety and Antitumor Activity in the Phase 1–2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer." Eur Urol 2015.